View Older Stories View More Recent Stories
-
Roth Capital Downgrades Integrated Device Technology (IDTI) to Neutral
-
KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares
-
Roth Capital Starts Hecla Mining (HL) at Buy
-
Tilly's, Inc. (TLYS) Prices 5.5M Class A Share Secondary Offering at $18.50/Sh
-
Tilly’s, Inc. Announces Pricing of Secondary Offering of 5,500,000 Shares of Class A Common Stock
-
MeetMe (MEET) PT Raised to $6 at Roth Capital; Reiterates Buy
-
KalVista Pharmaceuticals (KALV) Prices 4M Share Common Offering at $17/Sh
-
KalVista Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Obalon Therapeutics (OBLN) at Buy
-
Roth Capital Starts Cyclacel Pharmaceuticals (CYCC) at Buy
-
Tilly's, Inc. (TLYS) Announces Proposed 8.1M Class A Share Secondary Offering
-
Tilly’s, Inc. Announces Proposed Secondary Offering of 8,100,000 Shares of Class A Common Stock
-
Quantenna Communications (QTNA) PT Raised to $25 at Roth Capital
-
4 Key Points From Catalyst Pharma (CPRX) Management Meeting - Roth Capital
-
Pixelworks (PXLW) PT Raised to $7 at Roth Capital
-
RumbleOn, Inc. (RMBL) PT Raised to $12 at Roth Capital After Meeting with Management
-
Ambarella (AMBA) PT Lowered to $35 at Roth Capital
-
Eastside Reminds Holders of Call for Common Stock Purchase Warrants ("EASTW")
-
Semtech Corp. (SMTC) PT Raised to $54 at Roth Capital
-
Salesforce (CRM) Upside Driven By Strategic Investment, PT To $139 - Roth
-
Roth Capital Downgrades Tilray (TLRY) to Neutral Citing Valuation
-
Adesto Technologies to Participate at Upcoming Investor Events
-
NV5 Holdings (NVEE) PT Raised to $97 at Roth Capital
-
Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results
-
Roth Cuts Americas Silver Corporation (USAS) PT To $4.75 On Dollar Driven Commodity Pricing
-
Roth Capital Cuts First Majestic Silver (AG) PT To $7 On Dollar Strength
-
OSI Systems (OSIS) PT Raised to $89 at Roth Capital Following 4Q
-
New York & Co. (NWY) Viewed Favorably at Roth
-
New Age Beverages (NBEV) Prices 8.2M Share Common Stock Offering at $1.28/Share
-
New Age Beverages Corporation Prices Underwritten Public Offering Of $10.5 Million Of Common Stock
-
New Age Beverages (NBEV) Announces Proposed Common Share Offering
-
New Age Beverages Corporation Announces Proposed Public Offering Of Common Stock
-
ROTH Capital Partners to Host ROTH Internet of Things Corporate Access Day in San Francisco, Calif., on September 5, 2018
-
Bionano Genomics Announces Pricing of Initial Public Offering
-
Roth Capital Downgrades Lannett Co (LCI) to Neutral Citing High Debt
-
DIGITAL ALLY, INC. ANNOUNCES 2018 SECOND QUARTER OPERATING RESULTS
-
DIGITAL ALLY, INC. ANNOUNCES 2018 SECOND QUARTER OPERATING RESULTS
-
Restoration Robotics, Inc™ Announces Full Exercise and Closing of Underwriters’ Over-allotment Option
-
Roth Capital Upgrades LSI Industries (LYTS) to Buy Citing Attractive Risk/Reward
-
Ritter Pharmaceuticals (RTTR) PT Lowered to $10.25 at Roth Capital
-
Restoration Robotics (HAIR) PT Lowered to $6.50 at Roth Capital
-
Canadian Solar (CSIQ) Margin Guidance Offers A Bright Side To A Weak Report - Roth Capital
-
Remark Media (MARK) PT Raised to $13.75 at Roth Capital Following 2Q
-
Telkonet Announces Second Quarter 2018 Financial Results
-
Telkonet Announces Second Quarter 2018 Financial Results
-
Veritone (VERI) PT Lowered to $20 at Roth Capital
-
BioDelivery Sciences International (BDSI) PT Raised to $4.50 at Roth Capital
-
Roth Capital Starts Tilray (TLRY) at Buy
-
Apollo Closes Secondary Public Offering Of PlayAGS Common Stock
-
Syros Pharmaceuticals (SYRS) PT Lowered to $12 at Roth Capital
